NDC 0169-3204 – Fiasp
Insulin Aspart 100 [iU]/mL · Injection, Solution · Subcutaneous
Product NDC0169-3204
Product details
- Brand name
- Fiasp
- Generic name
- Insulin aspart injection
- Labeler
- Novo Nordisk
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA208751
- Marketed since
- October 20, 2017
- Listing expires
- December 31, 2026
- Pharmacologic class
- Insulin Analog
Active ingredients
- Insulin Aspart 100 [iU]/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0169-3204-15 | 5 SYRINGE, PLASTIC in 1 CARTON (0169-3204-15) / 3 mL in 1 SYRINGE, PLASTIC | Oct 20, 2017 |
| 0169-3204-97 sample | 1 SYRINGE, PLASTIC in 1 CARTON (0169-3204-97) / 3 mL in 1 SYRINGE, PLASTIC (0169-3204-90) | Oct 20, 2017 |
Recalls mentioning this NDC
- D-0613-2021 Apr 21, 2021 · Class I
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and… - D-0611-2021 Apr 21, 2021 · Class I
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and… - D-0612-2021 Apr 21, 2021 · Class I
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and…